申请人:Universita' Degli Studi di Bari
公开号:EP2759540A2
公开(公告)日:2014-07-30
The present invention relates to heterocyclic compounds of the general formula (II) which are ligands of the beta-3 adrenergic receptor and their use in therapy.
本发明涉及作为 beta-3
肾上腺素能受体
配体的通式(II)
杂环化合物及其在治疗中的应用。